V 150 (Kalydeco 150 mg)
Generic Name: ivacaftor
Pill imprint V 150 has been identified as Kalydeco 150 mg.
Kalydeco is used in the treatment of cystic fibrosis and belongs to the drug class CFTR potentiators. There is no proven risk in humans during pregnancy. Kalydeco 150 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- 150 mg
- Prescription only
hypromellose acetate succinate 06081224 (3 mm2/s)
sodium lauryl sulfate
FD&C Blue No. 2
polyethylene glycol 3350
More about Kalydeco (ivacaftor)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.